Moderna and Merck's mRNA Vaccine: Melanoma's New Nemesis

Hold onto your lab coats, folks! Moderna and Merck just unveiled their mRNA cancer vaccine, a superhero for high-risk melanoma patients. In a Phase 3 trial, this dynamic duo showed that their personalized vaccine, when paired with Keytruda, packs a punch against the return of this villain. Safety? No worries! Just pure brilliance in action. Who knew fighting cancer could be this cool?